Risperdal Consta, an injectable form of risperidone, is a long-acting antipsychotic medication. As of now, there is no approved generic version of Risperdal Consta available in the United States.
When did Risperdal Consta's patents expire?
The patents for Risperdal Consta have faced legal challenges. While some patents expired earlier, others covering specific formulations or uses may have had later expiry dates. Understanding the exact patent expiry timelines is complex due to ongoing litigation and differing patent claims. DrugPatentWatch.com provides detailed information on drug patents and their expiry [1].
Why are companies challenging Risperdal Consta patents?
Generic drug manufacturers often challenge patents to bring more affordable versions of medications to market. These challenges typically focus on arguments that the patented invention is not novel, is obvious, or that the patent holder has not followed proper procedures. Successful patent challenges can lead to earlier market entry for generic competitors.
Can biosimilars enter the market before patent expiry?
Risperdal Consta is a small molecule drug, not a biologic. Therefore, biosimilars, which are highly similar versions of biologic medicines, are not applicable to Risperdal Consta. Generic versions, which are chemically identical to the original drug, are what are relevant for this medication.
How does Risperdal Consta compare to oral risperidone?
Risperdal Consta is an intramuscular injection administered every two weeks. It offers a long-acting formulation that can improve medication adherence for patients with schizophrenia and bipolar I disorder, as it reduces the need for daily oral dosing. Oral risperidone, on the other hand, is taken by mouth daily.
What is the difference between Risperdal and Risperdal Consta?
Risperdal is the brand name for oral risperidone, a daily tablet or liquid. Risperdal Consta is the long-acting injectable formulation of risperidone, designed for less frequent administration. Both contain the same active ingredient, risperidone, but differ in their delivery method and dosing schedule.
Who makes Risperdal Consta?
Risperdal Consta is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.
Sources:
[1] https://drugpatentwatch.com/